Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...
Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...
Jeffrey Stark, MD, vice president and head of medical immunology at UCB, analyzes the Bimzelx Navigate program, a comprehensive support system developed to empower patients prescribed bimekizumab-bkzx ...
On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...
Atlas Health taps into financial assistance programs for patients to help hospitals get paid. AI connects the money, patients and health systems. At any given time, there are more than 20,000 ...
The Eliquis 360 Support program offers a 40% discount on apixaban, targeting uninsured or underinsured patients to improve access and affordability. Apixaban is the most prescribed oral anticoagulant ...
“I Have Constant Fear”: A National Qualitative Study on the Impact of COVID-19 on Cancer Care and Potential Solutions to Improve the Cancer Care Experience During the COVID-19 Pandemic We implemented ...
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
Health care costs in the United States continue to rise, placing greater financial pressure on health care purchasers and consumers. According to the KFF’s 2024 Employer Health Benefits Survey, ...
TOULOUSE, France, & BOSTON--(BUSINESS WIRE)--REEV, a pioneering medical technology startup developing intelligent, lightweight wearable robotics, on Tuesday announced a $9.2 million funding round to ...
Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or ...